The annual get-together in the Bavarian capital has meanwhile become a "must" for top international researchers in the field of diabetes and metabolic disorders. Leading experts and highly qualified young researchers from various disciplines in a personal and manageable ambience lend the science forum its unique nature.
The multidisciplinary program rises up to the primary challenge in modern diabetes research: multi-dimensional and clinically relevant approaches are closely examined and summarized. This year one special focus will be on the role of insulin-producing beta cells. The framework offers scientists, clinical researchers and biotechnology experts an opportunity for intensive discourse and interactions. In round table sessions, selected participants can discuss their scientific projects and ideas with leading experts.
The high concentration of international scientific leaders is characteristic of the conference organized by Prof. Dr. Matthias Tschöp and Prof. Dr. Heiko Lickert (both from Helmholtz Zentrum München and TU München): in past conferences, nearly half the participants came from abroad, representing more than 20 nations. Speakers and the audience are associated with distinguished research institutions, including universities such as Cambridge, Harvard and Yale. It is therefore no surprise that this conference has come to enjoy a reputation as the leading annual symposium in diabetes research.
The latest research results, some not yet published, presented by leading international researchers form the basis for an exchange of scientific information and networking. This is expected to lead to valuable synergies in the fight against diabetes. The fact that the WHO dedicated this year's World Health Day to diabetes shows how urgent this matter is.
The Helmholtz-Nature Medicine Diabetes Conference presents a number of prestigious awards each year. One of these is the Helmholtz Diabetes Award in recognition of the lifetime achievements of a senior leader in the field, which will be given to Sir Stephen O'Rahilly from Cambridge University this year. The Novo Nordisk - Helmholtz Young Investigator in Diabetes Award (HeIDi) will also be presented to one of the 20 nominated rising stars in research who will be presenting short lectures during the conference as they compete for this prestigious research prize. The the HelDi Award jury is a scientific panel consisting of independent scientists. The HelDi Award is sponsored by Novo Nordisk A/S.
You can find the preliminary program, including conference speakers and HeIDi nominees, and the registration information at the conference website: http://www.